COMMENTARY: understanding the benefits of pediatric anti-retroviral treatment in resource-limited settings.
Access to antiretroviral treatment in resource-limited settings has repeatedly demonstrated reduction in mortality. With more treatment options becoming available, the ability to optimize therapy will depend on population-specific clinical trial data. The role of nondrug factors for optimizing therapy and the potential for drug-related adverse events that are population-specific should not be underestimated.